A Phase 2, Open-label Study of PRAX-944 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Escalating Multiple Oral Doses in Adults with Generalized Epileptic Syndromes with Absence Seizures.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Germaine, Jack (Project Manager)

Project: Research

StatusActive
Effective start/end date9/10/1820/07/19